Bodycraft raises ₹120 crore from Singularity AMC to scale clinic-salon network across India
ADVERTISEMENT
Integrated beauty, wellness and medical aesthetics platform Bodycraft Clinic and Salon has raised ₹120 crore from Singularity AMC, a Mumbai-based private equity firm focused on growth-stage and pre-IPO investments in India.
The fundraise also marks Bodycraft’s first major funding round in nearly nine years. In 2017, the company had raised ₹18 crore at a pre-money valuation of ₹55 crore. The company has not publicly disclosed its current valuation.
The fresh capital will be used to expand Bodycraft’s footprint across India, strengthen clinical capabilities, invest in technology and AI-led operations, and enhance customer experience across its network.
Founded in Bengaluru in 1997 by Manjul Gupta, Bodycraft has evolved from a single salon into an integrated platform spanning salons, dermatology, aesthetics and wellness services. Today, the company operates 67 outlets—comprising 33 clinics and 34 salons—across more than 10 cities and plans to open 30 additional locations using the newly raised capital.
The company follows a hybrid expansion model comprising both company-owned and company-operated (COCO) and franchise-owned and franchise-operated (FOFO) formats.
What will drive Bodycraft’s next phase of growth?
The company’s expansion comes at a time when consumer spending on wellness and premium personal care continues to rise, driving formalisation across India’s fragmented beauty services market.
Bodycraft said a significant portion of the investment will also go towards clinical infrastructure, advanced equipment and improving operating efficiencies through artificial intelligence.
“This fundraise marks the beginning of an exciting new chapter for Bodycraft,” said Sahil Gupta, CEO, Bodycraft Clinics and Salons.
Over the years, the company has expanded beyond traditional salon services into dermatology, facial aesthetics, skin and hair treatments, and other medically supervised wellness offerings—creating a hybrid clinic-and-salon model that has become central to its positioning.
The clinical vertical, led by Medical Director Dr Mikki Singh, has emerged as one of the company’s growth drivers as demand rises for specialised aesthetic and preventive care services.
Industry estimates cited by the company suggest India’s clinical aesthetics market could grow from nearly $2 billion in 2024 to over $7 billion by 2033, while the broader beauty and personal care market is projected to expand from $27 billion in FY25 to nearly $39 billion by FY30.
Quest Profin Advisors acted as the exclusive investment banker on the transaction, while ALMT Legal advised on the deal.